主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NPCE
#2547
Neuropace, Inc. Common Stock
14.580
0
-0.95%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.95%
每月变动
-9.97%
6个月变化
+37.81%
年变化
+37.81%
前一天收盘价
14.720
0
Open
14.580
0
Bid
Ask
Low
14.580
0
High
14.580
0
交易量
30
市场
股票
医疗保健
NPCE
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
0
0
Dividend yield %
—
—
—
0
—
Payout ratio %
—
—
—
0
0
新闻
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates
Leerink Partners将NeuroPace股票目标价从19美元上调至20美元
NeuroPace stock price target raised to $20 from $19 at Leerink Partners
NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright
NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
NeuroPace股价上涨,UBS在强劲第四季度收入后重申买入评级
NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue
NeuroPace公司2025年收入增长25%,预计稳定增长
NeuroPace reports 25% revenue growth for 2025, projects steady growth